Novel Paenibacillus Strain, Antifungal Compounds, and Methods for Their Use
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 62/138,765, filed Mar 26, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,159,257 | Novel Paenibacillus Strain, Antifungal Compounds, and Methods for Their Use In force · High confidence | Bayer CropScience LLC | In force | High confidence | ||
| US 10,499,656 | Novel Paenibacillus Strain, Antifungal Compounds, and Methods for Their Use In force · High confidence | Bayer CropScience LLC | In force | High confidence | ||
| US 9,883,676 | Novel Paenibacillus Strain, Antifungal Compounds, and Methods for Their Use In force · High confidence | Bayer CropScience LLC | In force | High confidence | ||
| US 11,623,944 | Novel Paenibacillus Strain, Antifungal Compounds, and Methods for Their Use In force · High confidence | Bayer CropScience LLC | In force | High confidence | ||
| US 12,753,207 | Paenibacillus Strain, Antifungal Compounds, and Methods for Their Use In force · Medium confidence | Bayer CropScience LLC | In force | Medium confidence |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.